Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Agilik@Home: Demonstrate the Clinical Improvement Due to the Home Use of Agilik in Children With Cerebral Palsy

NCT06622655 is registered in ClinicalTrials.gov with IRCCS Eugenio Medea as lead sponsor.

NCT NCT06622655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06622655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Agilik@Home: Demonstrate the Clinical Improvement Due to the Home Use of Agilik in Children With Cerebral Palsy
Lead sponsor
IRCCS Eugenio Medea
Phase
Not applicable
Overall status
Recruiting
Start date
October 29, 2024
Completion date
November 30, 2026
Enrollment
40 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy (cp)